Pyxis Oncology (PYXS) Current Leases (2020 - 2025)

Pyxis Oncology (PYXS) has 5 years of Current Leases data on file, last reported at $1.7 million in Q4 2025.

• Current Leases for Q4 2025 came in at $1.7 million, up 16.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 million (up 16.69% YoY), and the FY2025 annual result was $1.7 million, up 16.69% from the prior year.
• Current Leases rose to $1.7 million in Q4 2025 per PYXS's latest filing, from $1.6 million in the prior quarter.
• Over five years, Current Leases peaked at $1.7 million in Q4 2025 and troughed at $165000.0 in Q4 2021.
• A 4-year average of $1.1 million and a median of $1.2 million in 2023 frame the typical range for Current Leases.
• The sharpest annual moves came in 2021 and 2025: Current Leases tumbled 73.17% in 2021, then jumped 47.84% in 2025.
• A 4-year view of Current Leases shows it stood at $165000.0 in 2021, then jumped by 646.67% to $1.2 million in 2023, then grew by 17.69% to $1.4 million in 2024, then increased by 16.69% to $1.7 million in 2025.
• Business Quant data shows PYXS's Current Leases at $1.7 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.